1.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: GEICAM 2001-01, NCT00128778
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: RPCI-DS-96-28, SEQUUS-30-38, NCI-G97-1241, NCT00002985
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SEQUUS-30-49, NCI-V97-1257
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1D96, AMC-009, SWOG-E1D96, CPMC-IRB-9905, NCT00003350, E1D96
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI
Protocol IDs: GOG-0182, SWOG-G0182, MRC-ICON5, ECOG-G0182, NCT00011986, ISRCTN41636183
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: SWOG-S0200, S0200, NCT00043082
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004579, NCT00097981
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TLK286.3024, NCT00102973
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004117, NCT00103506
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ET743-OVA-301, ET743-OVA-301, NCT00113607
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CALYPSO, EudraCT 2004-04456-39, NCT00189553
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CEPO906A2303, NCT00262990
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 66 and over
Sponsor: Other
Protocol IDs: IBCSG-32-05, BIG-CASA, EUDRACT-2005-003434-18, BIG-1-05, EU-205112, NCT00296010
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor: Other
Protocol IDs: MITO-2, EudraCT number 2005-004453-98, NCT00326456
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004120, DOXILBCA3001, NCT00091442
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TLK286.3025, NCT00350948
|
|
17.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GUMC-96007, VX-95-853-001, VX-GUMC-96007, NCI-V97-1275, NCT00004030
|
|
18.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-99054, LIPO-D9905, NCI-G00-1684, NCT00004925
|
|
19.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: CLB-59804, NCT00006029, CALGB-59804
|
|
20.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NYU-0012, ALZA-00-001-ii, NCI-G00-1878, NCT00006825
|
|
21.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: AGOSG-AGO-GYN-2, EU-20147, NCT00032162
|
|
22.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 16
Sponsor:
Protocol IDs: AECM-9003060, NCI-V90-0154
|
|
23.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TLK286.2011, NCT00052065
|
|
24.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UNC-LCCC-2020, NCT00237627
|
|
25.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: GEICAM 2003-03, NCT00129896
|
